Smith & Nephew’s (SN) Sector Perform Rating Reiterated at Royal Bank Of Canada

Smith & Nephew (LON:SN)‘s stock had its “sector perform” rating reissued by analysts at Royal Bank Of Canada in a report issued on Tuesday,London Stock Exchange reports. They presently have a GBX 1,350 target price on the stock. Royal Bank Of Canada’s price target would suggest a potential upside of 7.87% from the company’s current price.

SN has been the subject of a number of other research reports. Berenberg Bank reiterated a “hold” rating and set a GBX 1,300 price target on shares of Smith & Nephew in a research note on Friday, January 23rd. Panmure Gordon restated a “hold” rating and issued a GBX 1,200 price objective on shares of Smith & Nephew in a research note on Tuesday, December 9th. Two investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, Smith & Nephew presently has an average rating of “Hold” and a consensus target price of GBX 1,381.33.

Smith & Nephew Price Performance

Shares of SN stock remained flat at GBX 1,251.50 during trading hours on Tuesday. The stock had a trading volume of 1,618,325 shares, compared to its average volume of 343,671. The company has a quick ratio of 0.84, a current ratio of 2.57 and a debt-to-equity ratio of 62.90. The company has a market cap of £13.72 billion, a P/E ratio of 45.06, a price-to-earnings-growth ratio of 0.46 and a beta of 0.68. The business has a fifty day moving average of GBX 1,273.26 and a two-hundred day moving average of GBX 1,295.49.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.